These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 796914)

  • 1. Tumor inductions by cytostatics in man.
    Hunstein W
    Recent Results Cancer Res; 1975; (52):50-6. PubMed ID: 796914
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental investigations with anti-cancer drugs for carcinogenicity with special reference to immunedepression.
    Schmähl D
    Recent Results Cancer Res; 1975; (52):18-28. PubMed ID: 1234999
    [No Abstract]   [Full Text] [Related]  

  • 3. Iatrogenic carcinogenesis.
    Schmähl D
    J Cancer Res Clin Oncol; 1981; 99(1-2):71-5. PubMed ID: 7251640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor-induction through cytostatic agents in man].
    Hunstein W; Rehn K
    Dtsch Med Wochenschr; 1975 Jan; 100(4):155-8. PubMed ID: 1053991
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of anticancer drugs during pregnancy.
    Stutzman L; Sokal JE
    Clin Obstet Gynecol; 1968 Jun; 11(2):416-27. PubMed ID: 4879373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carcinogenicity of anticancer agents].
    Hayashi Y; Takahashi M; Yoshimura H
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2293-8. PubMed ID: 2260866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisystem stem cell failure after apparent recovery from alkylating agents.
    Botnick LE; Hannon EC; Hellman S
    Cancer Res; 1978 Jul; 38(7):1942-7. PubMed ID: 657132
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-activity relationships in the carcinogenicity of anticancer agents.
    Prejean JD; Montgomery JA
    Drug Metab Rev; 1984; 15(3):619-46. PubMed ID: 6386411
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiological studies of medically used drugs.
    Clemmesen J; Hjalgrim-Jensen S
    Arch Toxicol Suppl; 1980; 3():19-25. PubMed ID: 6930943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the biological alkylating agents.
    Haddow A
    Perspect Biol Med; 1973; 16(4):503-24. PubMed ID: 4593768
    [No Abstract]   [Full Text] [Related]  

  • 11. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 12. Second neoplasm--a complication of cancer chemotherapy.
    Chabner BA
    N Engl J Med; 1977 Jul; 297(4):213-5. PubMed ID: 876277
    [No Abstract]   [Full Text] [Related]  

  • 13. Treosulphan.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():341-7. PubMed ID: 6944265
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents].
    Schmähl D; Osswald H
    Arzneimittelforschung; 1970 Oct; 20(10):1461-7. PubMed ID: 5536412
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced cancer.
    Fraumeni JF; Miller RW
    J Natl Cancer Inst; 1972 May; 48(5):1267-70. PubMed ID: 4555495
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence of second tumors in man after anticancer drug treatment.
    Schmähl D; Habs M; Lorenz M; Wagner I
    Cancer Treat Rev; 1982 Sep; 9(3):167-94. PubMed ID: 7159878
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
    Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
    Schein PS; Winokur SH
    Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-lethal assay of selected cytostatics.
    Sýkora I; Gandalovicová D
    Neoplasma; 1978; 25(5):523-33. PubMed ID: 581697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy].
    Gianni AM; Bregni M; Siena S; Tarella C
    Haematologica; 1989 Oct; 74(5 Suppl):511-26. PubMed ID: 2574136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.